Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laheurte

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid TumorsLuis Teixeira, Jacques Medioni, Julie Garibal, et al.
Blood Advances|November 9, 2020
Processing methods and storage duration impact extracellular vesicle counts in red blood cell unitsClementine Gamonet, Maxime Desmarets, Guillaume Mourey, et al.
Oncoimmunology|May 4, 2018
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trialO Adotevi, Y Godet, J Galaine, et al.
Frontiers in Immunology|September 3, 2019
End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal TransplantationClémence Carron, Jean-Paul Pais de Barros, Emilie Gaiffe, et al.
Journal for Immunotherapy of Cancer|November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapySylvain Simon, Valentin Voillet, Virginie Vignard, et al.
Nature Medicine|August 10, 2023
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trialMarion Thibaudin, Jean-David Fumet, Benoist Chibaudel, et al.
Blood Cancer Journal|August 11, 2021
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignanciesFlorent Malard, Béatrice Gaugler, Joel Gozlan, et al.
Cancer Research|May 20, 2016
Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell ImmunityLaurent Beziaud, Laura Mansi, Patrice Ravel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2022
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation StudyOlivier Adotévi, Dewi Vernerey, Pascale Jacoulet, et al.
Research Square|November 24, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccinesAgathe Carrier, Paolo Manghi, Carolina Alves Costa Silva, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid TumorsLuis Teixeira, Jacques Medioni, Julie Garibal, et al.
Blood Advances|November 9, 2020
Processing methods and storage duration impact extracellular vesicle counts in red blood cell unitsClementine Gamonet, Maxime Desmarets, Guillaume Mourey, et al.
Oncoimmunology|May 4, 2018
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trialO Adotevi, Y Godet, J Galaine, et al.
Frontiers in Immunology|September 3, 2019
End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal TransplantationClémence Carron, Jean-Paul Pais de Barros, Emilie Gaiffe, et al.
Journal for Immunotherapy of Cancer|November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapySylvain Simon, Valentin Voillet, Virginie Vignard, et al.
Nature Medicine|August 10, 2023
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trialMarion Thibaudin, Jean-David Fumet, Benoist Chibaudel, et al.
Blood Cancer Journal|August 11, 2021
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignanciesFlorent Malard, Béatrice Gaugler, Joel Gozlan, et al.
Cancer Research|May 20, 2016
Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell ImmunityLaurent Beziaud, Laura Mansi, Patrice Ravel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2022
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation StudyOlivier Adotévi, Dewi Vernerey, Pascale Jacoulet, et al.
Research Square|November 24, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccinesAgathe Carrier, Paolo Manghi, Carolina Alves Costa Silva, et al.
Pageof 7